EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors affecting CRISPR-Cas defense against antibiotic resistance plasmids harboured by Enterococcus faecalis laboratory model strains and clinical isolates

Tahira Amdid Ratna, Belle Marco Sharon, Cesar Alejandro Barros Velin, Kelli Palmer

Microbiology · 23.09.2025 · 171 (9)

DOI: 10.1099/mic.0.001601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology, erschienen am 23.09.2025. Verfasst von Tahira Amdid Ratna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, The University of Texas at Dallas, Richardson, 75080, Texas, USA. Hauptthemen laut MEDLINE: Enterococcus faecalis, Plasmids, CRISPR-Cas Systems, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Cecil and Ida Green Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterococcus faecalis is a Gram-positive bacterium and opportunistic pathogen that acquires resistance to a wide range of antibiotics by horizontal gene transfer (HGT). The rapid increase of multidrug-resistant (MDR) bacteria including MDR E. faecalis necessitates the development of alternative therapies and a deeper understanding of the factors that impact HGT. CRISPR-Cas systems provide sequence-specific defense against HGT. From previous studies, we know that E. faecalis CRISPR-Cas provides sequence-specific anti-plasmid defense during agar plate biofilm mating and in the murine intestine. Those studies were mainly conducted using laboratory model strains with a single, CRISPR-targeted plasmid in the donor. MDR E. faecalis typically possess multiple plasmids that are diverse in sequence and may interact with each other to impact plasmid transfer and CRISPR-Cas efficacy. Here, we altered multiple parameters of our standard in vitro conjugation assays to assess CRISPR-Cas efficacy, including the number and genotype of plasmids in the donor, and laboratory model strains as donor versus recent human isolates as donor during conjugation. We found that the plasmids pTEF2 and pCF10, which are not targeted by CRISPR-Cas in our recipient, enhance the conjugative transfer of the CRISPR-targeted plasmid pTEF1 into both WT and CRISPR-Cas-deficient (via deletion of cas9 ) recipient cells. However, the effect of pTEF2 on pTEF1 transfer is much more pronounced, with a striking 6-log increase in pTEF1 conjugation frequency when pTEF2 is also present in the donor and recipients are deficient for CRISPR-Cas (compared with 4-log for pCF10). Overall, this study provides insight about the interplay between plasmids and CRISPR-Cas defence, opening avenues for developing novel therapeutic strategies to curb HGT among bacterial pathogens and highlighting pTEF2 as a plasmid for additional mechanistic study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterococcus faecalisPlasmidsCRISPR-Cas SystemsDrug Resistance, Multiple, BacterialGene Transfer, HorizontalConjugation, GeneticHumansAnti-Bacterial AgentsGram-Positive Bacterial Infections

Stichwörter der Autor:innen

CRISPR-CasEnterococcus faecalisantibiotic resistancehorizontal gene transfermobile genetic elementplasmid

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biological Sciences, The University of Texas at Dallas, Richardson, 75080, Texas, USA.

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Cecil and Ida Green Foundation

Zitieren

APA

Ratna, T. A., Sharon, B. M., Barros Velin, C. A., & Palmer, K. (2025). Factors affecting CRISPR-Cas defense against antibiotic resistance plasmids harboured by Enterococcus faecalis laboratory model strains and clinical isolates. Microbiology, 171(9). https://doi.org/10.1099/mic.0.001601

Vancouver

Ratna TA, Sharon BM, Barros Velin CA, Palmer K. Factors affecting CRISPR-Cas defense against antibiotic resistance plasmids harboured by Enterococcus faecalis laboratory model strains and clinical isolates. Microbiology. 2025;171(9). doi:10.1099/mic.0.001601

BibTeX
@article{Ratna2025,
  author = {Ratna, Tahira Amdid and Sharon, Belle Marco and Barros Velin, Cesar Alejandro and Palmer, Kelli},
  title = {Factors affecting CRISPR-Cas defense against antibiotic resistance plasmids harboured by Enterococcus faecalis laboratory model strains and clinical isolates},
  journal = {Microbiology},
  year = {2025},
  volume = {171},
  number = {9},
  doi = {10.1099/mic.0.001601}
}
Kostenlos starten →